Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Androgens help motor neurons grow by increasing neuritin.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Helping PCOS patients focus on hope and control can reduce depression.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Women with PCOS experience more psychological symptoms and need emotional support.